Ur-Energy Names Matthew Gili as Chief Executive Officer
Leadership Change: Ur-Energy Inc. has appointed Matthew D. Gili as the new Chief Executive Officer, effective December 13, succeeding John W. Cash.
Retirement Announcement: John W. Cash will retire on December 12 but will remain as Chairman of Ur-Energy.
Trade with 70% Backtested Accuracy
Analyst Views on URG
About URG
About the author
Trump Positions Nuclear Energy as Key to US Manufacturing Growth
- Nuclear Sector Rally: Following Trump's address at the World Economic Forum framing nuclear energy as a safe and efficient solution, nuclear stocks surged, indicating strong market confidence in the sector.
- Policy Initiatives: The executive orders mentioned by Trump aim to streamline nuclear reactor licensing and fast-track small modular reactors (SMRs), which are expected to further solidify the U.S. position as an energy superpower.
- Investor Enthusiasm: Stocks of companies like Oklo, Nano Nuclear Energy, and NuScale Power spiked in response to Trump's support for nuclear power, reflecting investor optimism in the nuclear industry.
- Economic Confidence: Trump asserted that the U.S. is the economic engine of the world, with all three major indexes rising, including a 0.32% increase in the S&P 500, showcasing market confidence in the recovery of the American economy.
Uranium and Nuclear-Related Stocks Rise Following President Trump's Remarks on Nuclear Energy at Davos Meeting
Uranium and Nuclear Stocks Surge: Shares of uranium and nuclear-linked stocks are experiencing a rise in trading activity.
Trump's Remarks at Davos: During the Davos meeting, President Trump emphasized the United States' strong commitment to nuclear energy.
Direxion Daily S&P 500 Bull 3X ETF Drops 3.1%, Applovin Falls 9.4%
- ETF Underperformance: The Direxion Daily S&P 500 Bull 3X ETF is down approximately 3.1% in Wednesday afternoon trading, indicating a decline in investor confidence that may affect short-term investment decisions.
- Component Stocks Decline: Within the ETF, Applovin shares fell about 9.4%, while Intuit dropped around 7.2%, reflecting poor market performance that could lead investors to reassess their future growth potential.
- Market Sentiment Fluctuation: The overall decline of the ETF, combined with the weak performance of its components, may raise investor concerns about tech stocks, potentially impacting capital flows and investment strategies in related sectors.
- Investor Reaction: As the Direxion ETF underperforms, investors might consider adjusting their portfolios towards more stable assets to navigate market uncertainties and volatility.
U.S. Stocks Rise on Venezuela Action; Chevron Shares Up 5.8%
- Market Rally: U.S. equities wrapped the first full trading week of 2026 on a strong note, with both the S&P 500 and Dow Jones Industrial Average reaching new record highs, reflecting investor optimism about economic recovery.
- Energy Stocks Surge: Following U.S. military actions in Venezuela, Chevron shares rose approximately 5.8%, as investors expressed optimism about potential access to the country's oil resources, highlighting the direct impact of geopolitical events on market performance.
- Defense Stocks Rise: Anticipation of a significantly larger Pentagon budget in 2027 led to substantial gains for defense contractors, indicating a strong market focus on defense spending and confidence in future growth prospects.
- Mixed Economic Data: The December jobs report revealed slower-than-expected payroll growth but a declining unemployment rate, easing investor concerns about labor market stress and supporting the narrative that the Fed may hold rates steady in the near term.
Kyverna Therapeutics, Immunome, Almonty Industries, and Other Major Stocks Rise on Monday
U.S. Stock Market Performance: U.S. stocks declined, with the Nasdaq Composite dropping over 100 points on Monday.
Kyverna Therapeutics Surge: Kyverna Therapeutics Inc. shares rose 31% to $11.49 following the announcement of positive topline data from its Phase 2 trial of mivocabtagene autoleucel for stiff person syndrome.
Other Notable Stock Gains: Beneficient, Immunome Inc., and Falcon’s Beyond Global recorded significant gains, with increases of 29.3%, 25.5%, and 14% respectively.
Additional Stock Movements: Several other companies, including Almonty Industries and NovaBay Pharmaceuticals, also saw notable increases in their stock prices, contributing to a generally positive day for select stocks despite the overall market decline.
Major Stocks Including Oxford Industries, Ur-Energy, and Oracle Decline in Thursday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures are down, with Nasdaq 100 futures dropping approximately 150 points on Thursday morning.
Oxford Industries Performance: Oxford Industries, Inc. shares fell 25.6% in pre-market trading after reporting a quarterly loss of 92 cents per share and issuing lower-than-expected fourth-quarter guidance.
Other Stocks Declining: Several other stocks also saw significant declines in pre-market trading, including CapsoVision Inc. (-16.6%), Ur-Energy Inc. (-12.1%), and Oracle Corporation (-11.3%).
Market Reactions: The market is reacting negatively to various earnings reports and guidance updates, leading to notable drops in stock prices across multiple companies.
Trump Positions Nuclear Energy as Key to US Manufacturing Growth
- Nuclear Sector Rally: Following Trump's address at the World Economic Forum framing nuclear energy as a safe and efficient solution, nuclear stocks surged, indicating strong market confidence in the sector.
- Policy Initiatives: The executive orders mentioned by Trump aim to streamline nuclear reactor licensing and fast-track small modular reactors (SMRs), which are expected to further solidify the U.S. position as an energy superpower.
- Investor Enthusiasm: Stocks of companies like Oklo, Nano Nuclear Energy, and NuScale Power spiked in response to Trump's support for nuclear power, reflecting investor optimism in the nuclear industry.
- Economic Confidence: Trump asserted that the U.S. is the economic engine of the world, with all three major indexes rising, including a 0.32% increase in the S&P 500, showcasing market confidence in the recovery of the American economy.
Uranium and Nuclear-Related Stocks Rise Following President Trump's Remarks on Nuclear Energy at Davos Meeting
Uranium and Nuclear Stocks Surge: Shares of uranium and nuclear-linked stocks are experiencing a rise in trading activity.
Trump's Remarks at Davos: During the Davos meeting, President Trump emphasized the United States' strong commitment to nuclear energy.
Direxion Daily S&P 500 Bull 3X ETF Drops 3.1%, Applovin Falls 9.4%
- ETF Underperformance: The Direxion Daily S&P 500 Bull 3X ETF is down approximately 3.1% in Wednesday afternoon trading, indicating a decline in investor confidence that may affect short-term investment decisions.
- Component Stocks Decline: Within the ETF, Applovin shares fell about 9.4%, while Intuit dropped around 7.2%, reflecting poor market performance that could lead investors to reassess their future growth potential.
- Market Sentiment Fluctuation: The overall decline of the ETF, combined with the weak performance of its components, may raise investor concerns about tech stocks, potentially impacting capital flows and investment strategies in related sectors.
- Investor Reaction: As the Direxion ETF underperforms, investors might consider adjusting their portfolios towards more stable assets to navigate market uncertainties and volatility.
U.S. Stocks Rise on Venezuela Action; Chevron Shares Up 5.8%
- Market Rally: U.S. equities wrapped the first full trading week of 2026 on a strong note, with both the S&P 500 and Dow Jones Industrial Average reaching new record highs, reflecting investor optimism about economic recovery.
- Energy Stocks Surge: Following U.S. military actions in Venezuela, Chevron shares rose approximately 5.8%, as investors expressed optimism about potential access to the country's oil resources, highlighting the direct impact of geopolitical events on market performance.
- Defense Stocks Rise: Anticipation of a significantly larger Pentagon budget in 2027 led to substantial gains for defense contractors, indicating a strong market focus on defense spending and confidence in future growth prospects.
- Mixed Economic Data: The December jobs report revealed slower-than-expected payroll growth but a declining unemployment rate, easing investor concerns about labor market stress and supporting the narrative that the Fed may hold rates steady in the near term.
Kyverna Therapeutics, Immunome, Almonty Industries, and Other Major Stocks Rise on Monday
U.S. Stock Market Performance: U.S. stocks declined, with the Nasdaq Composite dropping over 100 points on Monday.
Kyverna Therapeutics Surge: Kyverna Therapeutics Inc. shares rose 31% to $11.49 following the announcement of positive topline data from its Phase 2 trial of mivocabtagene autoleucel for stiff person syndrome.
Other Notable Stock Gains: Beneficient, Immunome Inc., and Falcon’s Beyond Global recorded significant gains, with increases of 29.3%, 25.5%, and 14% respectively.
Additional Stock Movements: Several other companies, including Almonty Industries and NovaBay Pharmaceuticals, also saw notable increases in their stock prices, contributing to a generally positive day for select stocks despite the overall market decline.
Major Stocks Including Oxford Industries, Ur-Energy, and Oracle Decline in Thursday's Pre-Market Trading
U.S. Stock Futures: U.S. stock futures are down, with Nasdaq 100 futures dropping approximately 150 points on Thursday morning.
Oxford Industries Performance: Oxford Industries, Inc. shares fell 25.6% in pre-market trading after reporting a quarterly loss of 92 cents per share and issuing lower-than-expected fourth-quarter guidance.
Other Stocks Declining: Several other stocks also saw significant declines in pre-market trading, including CapsoVision Inc. (-16.6%), Ur-Energy Inc. (-12.1%), and Oracle Corporation (-11.3%).
Market Reactions: The market is reacting negatively to various earnings reports and guidance updates, leading to notable drops in stock prices across multiple companies.
